UNITY BIOTECHNOLOGY INC's ticker is UBX and the CUSIP is 91381U101. A total of 74 filers reported holding UNITY BIOTECHNOLOGY INC in Q1 2020. The put-call ratio across all filers is 0.04 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $430,723 | -94.1% | 157,198 | -90.0% | 0.23% | -97.2% |
| Q2 2021 | $7,294,000 | -99.9% | 1,571,981 | 0.0% | 8.07% | -25.7% |
| Q1 2021 | $9,431,886,000 | +114406.3% | 1,571,981 | 0.0% | 10.86% | +9.6% |
| Q4 2020 | $8,237,000 | +51.4% | 1,571,981 | 0.0% | 9.91% | +35.2% |
| Q3 2020 | $5,439,000 | -60.1% | 1,571,981 | 0.0% | 7.33% | -43.9% |
| Q2 2020 | $13,645,000 | +49.7% | 1,571,981 | 0.0% | 13.06% | -43.4% |
| Q1 2020 | $9,117,000 | -19.6% | 1,571,981 | 0.0% | 23.05% | +79.3% |
| Q4 2019 | $11,334,000 | – | 1,571,981 | – | 12.85% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Mayo Clinic | 1,571,981 | $7,294,000 | 8.07% |
| Invus Financial Advisors, LLC | 1,094,998 | $5,081,000 | 1.01% |
| Founders Fund V Management, LLC | 491,751 | $2,282,000 | 0.78% |
| Tibra Equities Europe Ltd | 80,700 | $374,000 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 205,882 | $955,000 | 0.11% |
| Hall Private Wealth Advisors | 18,500 | $86,000 | 0.06% |
| 20/20 Capital Management, Inc. | 42,840 | $199,000 | 0.05% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 64,789 | $301,000 | 0.05% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 759,918 | $3,526,000 | 0.02% |
| PDT Partners, LLC | 74,178 | $344,000 | 0.02% |